₹23.40
−4.88%NSE close, 16 Nov 2026
−31.28%
MEDICAMEN ORGANICS is a small cap company, listed on NSE SME under the symbol MEDIORG. At ₹23.40 a share, the market values the whole company at ₹35 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹23 crore and a net loss of ₹4 crore, an operating margin of -16.6%.
The market values the company at 1.02 times its book value; its return on equity is -29.9% and its borrowings are 0.35 times its equity.
Promoters hold 51.44% of the shares. Foreign institutions hold 0.13%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has fallen 26.1%, and it is 26.9% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | Sep 2024 S | 6M to Mar 2025 | 6M to Sep 2025 | 6M to Mar 2026 | 6M to Sep 20261 |
|---|---|---|---|---|---|
| Sales | 16.6 | 21.6 | 17.9 | 4.8 | 7.0 |
| Expenses |
The financial results for the period ended September 30, 2026.
The financial results for the period ended September 30, 2026.
Submission of Certificate from Statutory Auditors in terms of Regulation 169(5) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018
Allotment of 10,00,000 (Ten Lakhs) fully paid-up Equity Shares pursuant to conversion of 10,00,000 (Ten Lakhs) fully convertible warrants, on a preferential basis
Change in Auditors of the company.
| 17.7 |
| 14.4 |
| 12.0 |
| 10.4 |
| Operating profit | 2.5 | 3.9 | 3.4 | −7.2 | −3.5 |
|---|
| Operating margin | 15.2% | 17.8% | 19.2% | -150.2% | -49.4% |
|---|
| Other income | 0.3 | 0.1 | 0.1 | 0.0 | 0.1 |
|---|
| Interest | 0.2 | 0.3 | 0.3 | 0.4 | 0.4 |
|---|
| Depreciation | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 |
|---|
| Profit before tax | 2.2 | 3.2 | 2.7 | −8.0 | −4.3 |
|---|
| Tax | 0.7 | 0.7 | 0.7 | −2.0 | −0.1 |
|---|
| Net profit | 1.5 | 2.5 | 2.0 | −6.1 | – |
|---|
| EPS (₹) | 1.48 | 2.19 | 1.74 | -5.15 | – |
|---|
₹ crore, financial years to March.
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|
| From operations | 0.9 | −4.6 | −8.2 |
| From investing | 0.1 | −1.7 | −0.4 |
| From financing | 3.3 | 3.5 | 9.9 |
| Spent on fixed assets | 0 | −1.7 | −0.3 |
| Free cash flow | 0.9 | −6.3 | −8.5 |
Margins, returns, debt, tax and cash.
| Line | FY25 | FY26 |
|---|---|---|
| Net margin | 10.6% | -17.8% |
| Operating margin | 17.3% | -16.6% |
| Return on equity | 13.8% | -14.0% |
| Return on capital employed | 14.2% | -10.6% |
| Return on assets | 6.8% | -7.8% |
| Debt to equity | 0.42 | 0.50 |
| Interest coverage | 11.60 | -6.40 |
| Debt to assets | 0.21 | 0.28 |
| Current ratio | 1.67 | 1.69 |
| Quick ratio | 1.40 | 1.21 |
| Cash ratio | 0.15 | 0.06 |
| Asset turnover | 0.64 | 0.44 |
| Fixed asset turnover | 3.77 | 1.76 |
| Inventory turnover | 2.90 | 1.50 |
| Receivables turnover | 1.50 | 1.20 |
| Gross margin | 43.9% | 30.2% |
| Cash from operations to profit | 21.0% | – |
| Effective tax rate | 25.4% | – |
Proceedings of undefined held on September 25, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
The letter dispatched to the Members of the Company containing the exact path to access the Annual Report for the F.Y. 2025-26.
Notice of Annual General Meeting to be held on September 25, 2026 along with the Annual Report for the financial year 2025-26.
Outcome of Board Meeting held on August 27, 2026.
Outcome of Board Meeting held on August 27, 2026.
Cessation of Mr Brijesh Kumar Chaubey as Executive Director of the company w.e.f. July 20, 2026.